Dyadic International (DYAI) Current Taxes (2017)
Dyadic International (DYAI) posted Current Taxes of $100675.0 for Q4 2017.
Dyadic International (DYAI) Current Taxes (2017) Analysis & Trends
Dyadic International has reported Current Taxes for 1 years, with the latest figure at $100675.0 in Q4 2017.
- Quarterly Current Taxes changed N/A year-over-year to $100675.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $100675.0 (changed N/A YoY) and the FY2017 annual result came in at $100675.0, changed N/A from the prior year.
- Current Taxes steadied at $100675.0 in Q4 2017 per DYAI's latest filing.
- Over five years, Current Taxes peaked at $100675.0 in Q4 2017 and troughed at $100675.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 100,675.00 |